Hillsdale Investment Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,000	Closed	-$3.86M	–	658
2024 Q2	$3.86M	Buy	+21,000	New	+$3.86M	0.3%	112